Large-scale stopping and switching treatment with COX-2 inhibitors after the rofecoxib withdrawal. [electronic resource]
Producer: 20080229Description: 9-19 p. digitalISSN:- 1053-8569
- Anti-Inflammatory Agents, Non-Steroidal -- adverse effects
- Arthritis, Rheumatoid -- drug therapy
- Cardiovascular Diseases -- prevention & control
- Cohort Studies
- Cyclooxygenase 2 Inhibitors -- administration & dosage
- Databases, Factual
- Drug Prescriptions -- statistics & numerical data
- Drug Therapy, Combination
- Drug Utilization Review
- Drug and Narcotic Control
- Female
- Gastrointestinal Diseases -- chemically induced
- Humans
- Lactones -- administration & dosage
- Male
- Middle Aged
- Practice Patterns, Physicians' -- statistics & numerical data
- Proton Pump Inhibitors
- Sulfones -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.